2 false false false false false false false false false false true false false true false true true No description of principal activity 2023-06-01 Sage Accounts Production Advanced 2023 - FRS102_2023 110,310 141,464 50,890 50,890 8,482 8,482 42,408 xbrli:pure xbrli:shares iso4217:GBP 10168610 2023-06-01 2024-05-31 10168610 2024-05-31 10168610 2023-05-31 10168610 2022-06-01 2023-05-31 10168610 2023-05-31 10168610 2022-05-31 10168610 bus:RegisteredOffice 2023-06-01 2024-05-31 10168610 bus:Director1 2023-06-01 2024-05-31 10168610 bus:Director2 2023-06-01 2024-05-31 10168610 core:WithinOneYear 2024-05-31 10168610 core:WithinOneYear 2023-05-31 10168610 core:MotorVehicles 2024-05-31 10168610 core:MotorVehicles 2023-06-01 2024-05-31 10168610 core:RetainedEarningsAccumulatedLosses 2023-06-01 2024-05-31 10168610 core:RetainedEarningsAccumulatedLosses 2022-06-01 2023-05-31 10168610 bus:AllOrdinaryShares 2023-06-01 2024-05-31 10168610 bus:AllOrdinaryShares 2022-06-01 2023-05-31 10168610 core:RetainedEarningsAccumulatedLosses 2023-05-31 10168610 core:RetainedEarningsAccumulatedLosses 2022-05-31 10168610 core:RetainedEarningsAccumulatedLosses 2024-05-31 10168610 core:RetainedEarningsAccumulatedLosses 2023-05-31 10168610 core:ShareCapital 2024-05-31 10168610 core:ShareCapital 2023-05-31 10168610 bus:SmallEntities 2023-06-01 2024-05-31 10168610 bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 10168610 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 10168610 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 10168610 bus:FullAccounts 2023-06-01 2024-05-31 10168610 1 2023-06-01 2024-05-31
COMPANY REGISTRATION NUMBER: 10168610
ARMAN MEDICAL SERVICES LIMITED
Unaudited Financial Statements
31 May 2024
ARMAN MEDICAL SERVICES LIMITED
Financial Statements
Year ended 31 May 2024
Contents
Page
Directors' report
1
Statement of income and retained earnings
2
Statement of financial position
3
Notes to the financial statements
4
ARMAN MEDICAL SERVICES LIMITED
Directors' Report
Year ended 31 May 2024
The directors present their report and the unaudited financial statements of the company for the year ended 31 May 2024 .
Directors
The directors who served the company during the year were as follows:
S M Qureshi
N Parveen
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 16 October 2024 and signed on behalf of the board by:
S M Qureshi
Director
Registered office:
c/o The Accounting Centre Limited
First Floor, 736 High Road
North Finchley
London
N12 9QD
ARMAN MEDICAL SERVICES LIMITED
Statement of Income and Retained Earnings
Year ended 31 May 2024
2024
2023
Note
£
£
Turnover
165,153
199,129
---------
---------
Gross profit
165,153
199,129
Administrative expenses
35,546
22,521
---------
---------
Operating profit
129,607
176,608
Other interest receivable and similar income
82
---------
---------
Profit before taxation
5
129,689
176,608
Tax on profit
19,379
35,144
---------
---------
Profit for the financial year and total comprehensive income
110,310
141,464
---------
---------
Dividends paid and payable
6
( 40,500)
( 58,000)
Retained earnings at the start of the year
140,651
57,187
---------
---------
Retained earnings at the end of the year
210,461
140,651
---------
---------
All the activities of the company are from continuing operations.
ARMAN MEDICAL SERVICES LIMITED
Statement of Financial Position
31 May 2024
2024
2023
Note
£
£
Fixed assets
Tangible assets
7
42,408
Current assets
Debtors
8
26,167
17,603
Cash at bank and in hand
166,668
162,632
---------
---------
192,835
180,235
Creditors: amounts falling due within one year
9
24,662
39,464
---------
---------
Net current assets
168,173
140,771
---------
---------
Total assets less current liabilities
210,581
140,771
---------
---------
Net assets
210,581
140,771
---------
---------
Capital and reserves
Called up share capital
120
120
Profit and loss account
10
210,461
140,651
---------
---------
Shareholders funds
210,581
140,771
---------
---------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 16 October 2024 , and are signed on behalf of the board by:
S M Qureshi
Director
Company registration number: 10168610
ARMAN MEDICAL SERVICES LIMITED
Notes to the Financial Statements
Year ended 31 May 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is c/o The Accounting Centre Limited, First Floor, 736 High Road, North Finchley, London, N12 9QD.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover represents the total amount receivable in the ordinary course of business for services provided.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles
-
over 4 years
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
5. Profit before taxation
Profit before taxation is stated after charging:
2024
2023
£
£
Depreciation of tangible assets
8,482
-------
----
6. Dividends
2024
2023
£
£
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year )
40,500
58,000
--------
--------
7. Tangible assets
Motor vehicles
£
Cost
At 1 June 2023
Additions
50,890
--------
At 31 May 2024
50,890
--------
Depreciation
At 1 June 2023
Charge for the year
8,482
--------
At 31 May 2024
8,482
--------
Carrying amount
At 31 May 2024
42,408
--------
At 31 May 2023
--------
8. Debtors
2024
2023
£
£
Trade debtors
26,167
17,500
Other debtors
103
--------
--------
26,167
17,603
--------
--------
9. Creditors: amounts falling due within one year
2024
2023
£
£
Accruals and deferred income
4,315
4,108
Corporation tax
19,379
35,144
Social security and other taxes
67
212
Director loan accounts
901
--------
--------
24,662
39,464
--------
--------
10. Reserves
Profit and loss account - This reserve records retained earnings and accumulated losses.
11. Directors' advances, credits and guarantees
The company owed to the directors £901 (2023: £103) at the year end.
12. Controlling party
The company was under the control of its directors throughout the year.